- $1.85bn
- $1.80bn
- $465.31m
- 80
- 24
- 95
- 75
Annual balance sheet for AtriCure, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 244 | 119 | 121 | 137 | 123 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 23.1 | 33 | 42.7 | 52.5 | 60.3 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 307 | 196 | 215 | 266 | 268 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 30.2 | 36.2 | 42.6 | 46.8 | 47.4 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 715 | 615 | 585 | 614 | 609 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 49.1 | 56.4 | 58.4 | 74.6 | 73.4 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 302 | 132 | 129 | 148 | 148 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 412 | 484 | 457 | 466 | 461 |
| Total Liabilities & Shareholders' Equity | 715 | 615 | 585 | 614 | 609 |
| Total Common Shares Outstanding |